Optibrium Widens Access to Industry-Leading Docking Method
New PyMOL interface extends access to Optibrium’s structure-based design method Surflex-Dock CAMBRIDGE, UK, 04 February 2025 – Optibrium, a leading…
Tamsin Mansley, PhD
President, Optibrium Inc. and Global Head of Application Science
Tamsin is an experienced drug discovery scientist, problem solver, and leader with over 20 years in the field. She currently heads Optibrium’s Application Science team, equipping customers with the resources they need for success.
Tamsin holds a PhD in Organic Chemistry from the University of East Anglia, UK, and pursued postdoctoral research in Professor Philip Magnus’s lab at the University of Texas, Austin. She began her career as a medicinal chemist at leading biopharma companies, including Eli Lilly and UCB, before transitioning into application science roles at Tripos, Dotmatics and OpenEye.
Her journey from bench to business leadership reflects a deep commitment to enabling better science through technology, collaboration, and innovation. Tamsin is passionate about improving the way research is done, helping scientists turn data into insights and discoveries more efficiently.
Latest news from Optibrium
Optibrium demonstrates superior molecular docking method for small molecules and macrocycles
CAMBRIDGE, UK, 22 October 2024 – Optibrium, a leading developer of software and AI solutions for molecular design today announced…
7th RSC-BMCS AI in chemistry conference
The Chemical Information & Computer Applications Group (CICAG) and Biological & Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry are once again organising a conference to present the current advances in AI and machine learning in Chemistry.
